ANGPTL4 and nephrotic syndrome: Though initial observational and animal model studies supported Angptl4 as a potential key player in the development of nephrotic syndrome and therefore a reasonable candidate biomarker, evaluation in patients with nephrotic syndrome has yielded conflicting results.